000 | 01536 a2200433 4500 | ||
---|---|---|---|
005 | 20250517014620.0 | ||
264 | 0 | _c20160126 | |
008 | 201601s 0 0 eng d | ||
022 | _a1538-8514 | ||
024 | 7 |
_a10.1158/1535-7163.MCT-14-0924 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeonard, John E | |
245 | 0 | 0 |
_aNonclinical Safety Evaluation of VX15/2503, a Humanized IgG4 Anti-SEMA4D Antibody. _h[electronic resource] |
260 |
_bMolecular cancer therapeutics _cApr 2015 |
||
300 |
_a964-72 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
650 | 0 | 4 | _aLymphocyte Count |
650 | 0 | 4 | _aMacaca fascicularis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aSemaphorins _xantagonists & inhibitors |
650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
700 | 1 | _aFisher, Terrence L | |
700 | 1 | _aWinter, Laurie A | |
700 | 1 | _aCornelius, Chad A | |
700 | 1 | _aReilly, Christine | |
700 | 1 | _aSmith, Ernest S | |
700 | 1 | _aZauderer, Maurice | |
773 | 0 |
_tMolecular cancer therapeutics _gvol. 14 _gno. 4 _gp. 964-72 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-14-0924 _zAvailable from publisher's website |
999 |
_c24599914 _d24599914 |